| Hans-Günter Meyer-Thompson | Hepatitiden
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study.
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study.
Ilhame A, Cécile D, Camelia P, David M, Joris H, Adélaïde P, Danièle B, Patrizia C, Perrine R.
Harm Reduct J. 2023 Jul 29;20(1):98. doi: 10.1186/s12954-023-00841-7. PMID: 37516889; PMCID: PMC10387207.